ENOS antibody (AA 519-690)
Quick Overview for ENOS antibody (AA 519-690) (ABIN7178985)
Target
See all ENOS (NOS3) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 519-690
-
Cross-Reactivity
- Rat
-
Purification
- >95%, Protein G purified
-
Immunogen
- Recombinant Rat Nitric oxide synthase, endothelial protein (519-690AA)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))
-
Alternative Name
- Nos3
-
Background
-
Background: Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets.
Aliases: Nos3 antibody, Nitric oxide synthase antibody, endothelial antibody, EC 1.14.13.39 antibody, Constitutive NOS antibody, cNOS antibody, EC-NOS antibody, Endothelial NOS antibody, eNOS antibody, NOS type III antibody, NOSIII antibody
-
UniProt
- Q62600
-
Pathways
- ACE Inhibitor Pathway, Regulation of Systemic Arterial Blood Pressure by Hormones, Cellular Response to Molecule of Bacterial Origin, Myometrial Relaxation and Contraction, Signaling Events mediated by VEGFR1 and VEGFR2, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Target
-